Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss?
Abstract Background Behçet disease is a relapsing, chronic, systemic inflammatory illness characterized by mucocutaneous, articular, neurological, urogenital, vascular, intestinal, and pulmonary symptoms in addition to recurrent aphthous stomatitis, genital ulcerations, and ophthalmic disease. Objec...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-05-01
|
| Series: | Egyptian Rheumatology and Rehabilitation |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43166-025-00326-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850190912778403840 |
|---|---|
| author | Dina Osman Mervat Bahiri Noha Hassan Yumn Elsabbagh |
| author_facet | Dina Osman Mervat Bahiri Noha Hassan Yumn Elsabbagh |
| author_sort | Dina Osman |
| collection | DOAJ |
| description | Abstract Background Behçet disease is a relapsing, chronic, systemic inflammatory illness characterized by mucocutaneous, articular, neurological, urogenital, vascular, intestinal, and pulmonary symptoms in addition to recurrent aphthous stomatitis, genital ulcerations, and ophthalmic disease. Objectives Assessing effect of disease symptomatology and drugs used on sensorineural hearing loss severity. Methods In this study, 60 adult Behçet disease patients participated. All underwent a comprehensive medical history, a basic audiological assessment, a Behçet disease current activity form, and a tinnitus handicap inventory scale. Results Sixty percent of the participants, had sensorineural hearing loss; over half (55.6%) had mild sensorineural hearing loss, there is no statistically significant correlation between the duration, the Behçet disease current activity form score, the tinnitus handicap inventory scale, vascular symptoms, and sensorineural hearing loss. Conclusions Prevalence of sensorineural hearing loss is 60%. Auditory manifestations and hemoglobin (HB) level are independent factors for sensorineural hearing loss (SNHL), no relation between disease manifestation, duration, disease activity, drugs and severity of hearing loss, no relation between level of platelets, HB, total leukocyte count (TLC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and severity of hearing loss. |
| format | Article |
| id | doaj-art-ccd2b6aec0234e218914e113c11bb9fd |
| institution | OA Journals |
| issn | 2090-3235 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Egyptian Rheumatology and Rehabilitation |
| spelling | doaj-art-ccd2b6aec0234e218914e113c11bb9fd2025-08-20T02:15:07ZengSpringerOpenEgyptian Rheumatology and Rehabilitation2090-32352025-05-0152111010.1186/s43166-025-00326-4Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss?Dina Osman0Mervat Bahiri1Noha Hassan2Yumn Elsabbagh3Cairo UniversityCairo UniversityCairo UniversityCairo UniversityAbstract Background Behçet disease is a relapsing, chronic, systemic inflammatory illness characterized by mucocutaneous, articular, neurological, urogenital, vascular, intestinal, and pulmonary symptoms in addition to recurrent aphthous stomatitis, genital ulcerations, and ophthalmic disease. Objectives Assessing effect of disease symptomatology and drugs used on sensorineural hearing loss severity. Methods In this study, 60 adult Behçet disease patients participated. All underwent a comprehensive medical history, a basic audiological assessment, a Behçet disease current activity form, and a tinnitus handicap inventory scale. Results Sixty percent of the participants, had sensorineural hearing loss; over half (55.6%) had mild sensorineural hearing loss, there is no statistically significant correlation between the duration, the Behçet disease current activity form score, the tinnitus handicap inventory scale, vascular symptoms, and sensorineural hearing loss. Conclusions Prevalence of sensorineural hearing loss is 60%. Auditory manifestations and hemoglobin (HB) level are independent factors for sensorineural hearing loss (SNHL), no relation between disease manifestation, duration, disease activity, drugs and severity of hearing loss, no relation between level of platelets, HB, total leukocyte count (TLC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and severity of hearing loss.https://doi.org/10.1186/s43166-025-00326-4Behçet diseaseSensorineural hearing lossBehçet disease current activity form |
| spellingShingle | Dina Osman Mervat Bahiri Noha Hassan Yumn Elsabbagh Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss? Egyptian Rheumatology and Rehabilitation Behçet disease Sensorineural hearing loss Behçet disease current activity form |
| title | Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss? |
| title_full | Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss? |
| title_fullStr | Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss? |
| title_full_unstemmed | Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss? |
| title_short | Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss? |
| title_sort | behcet disease do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss |
| topic | Behçet disease Sensorineural hearing loss Behçet disease current activity form |
| url | https://doi.org/10.1186/s43166-025-00326-4 |
| work_keys_str_mv | AT dinaosman behcetdiseasedoindividualsymptomatologyorcertaindrugintakereflecttheseverityofsensoryneuralhearingloss AT mervatbahiri behcetdiseasedoindividualsymptomatologyorcertaindrugintakereflecttheseverityofsensoryneuralhearingloss AT nohahassan behcetdiseasedoindividualsymptomatologyorcertaindrugintakereflecttheseverityofsensoryneuralhearingloss AT yumnelsabbagh behcetdiseasedoindividualsymptomatologyorcertaindrugintakereflecttheseverityofsensoryneuralhearingloss |